Phase II trial of fulvestrant in the treatment of recurrent ovarian carcinoma

被引：1
|
作者：
Thomas, S. G. [1 ]
Judson, P. L. [1 ]
Carson, L. F. [1 ]
Downs, L. S., Jr. [1 ]
Gliebre, R. G. [1 ]
Geller, M. A. [1 ]
Jonson, A. L. [1 ]
Argenta, P. A. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 111卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2008.07.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页码：374 / 375
页数：2
相关论文
共 50 条
  • [41] BROMOCRIPTINE IN THE TREATMENT OF CARCINOMA OF THE CERVIX - A PHASE II TRIAL
    RUGE, S
    PAGEL, J
    HORDING, U
    GYNECOLOGIC ONCOLOGY, 1985, 21 (03) : 356 - 358
  • [42] Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment
    Lee, Jung-Min
    Annunziata, Christina M.
    Hays, John L.
    Cao, Liang
    Choyke, Peter
    Yu, Minshu
    An, Daniel
    Turkbey, Ismail Baris
    Minasian, Lori M.
    Steinberg, Seth M.
    Chen, Helen
    Wright, John
    Kohn, Elise C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 88 - 94
  • [43] Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial
    Ye, Shuang
    Fu, Yi
    Liu, Shuai
    Wang, Jun
    Zhou, Lin
    Jiang, Wei
    Pei, Xuan
    Shen, Wenbin
    Sun, Min
    Shan, Boer
    Yang, Huijuan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A262 - A263
  • [44] Tamoxifen in the treatment of recurrent ovarian carcinoma
    Marth, C
    Sorheim, N
    Kaern, J
    Trope, C
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (04) : 256 - 261
  • [45] Tamoxifen in the treatment of recurrent ovarian carcinoma
    Tropé, C
    Marth, C
    Kaern, J
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S59 - S61
  • [46] A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium
    Welch, S.
    Mackay, H. J.
    Hirte, H.
    Fleming, G. F.
    Morgan, R.
    Wang, L.
    Blattler, C.
    Ivy, S. P.
    Oza, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study
    Hoffman, MA
    Blessing, JA
    Lentz, SS
    GYNECOLOGIC ONCOLOGY, 2003, 89 (01) : 95 - 98
  • [48] A phase II trial of bryostatin-I administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma
    Clamp, AR
    Blackhall, F
    Vasey, P
    Soukop, M
    Coleman, R
    Halbert, G
    Robson, L
    Jayson, GC
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1152 - 1154
  • [49] A phase II trial of CI-958 in recurrent platinum-sensitive ovarian carcinoma:: A gynecologic oncology group study
    Hoffman, MA
    Blessing, JA
    Nuñez, ER
    GYNECOLOGIC ONCOLOGY, 2001, 81 (03) : 433 - 435
  • [50] A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN RECURRENT EPITHELIAL OVARIAN-CARCINOMA
    LOOK, KY
    MUSS, HB
    BLESSING, JA
    MORRIS, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (01): : 19 - 22
12345